EMBECTA CORP. Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
EMBECTA CORP. (EMBC) had Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals of $20.10 million as of 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense › Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals · last filed 2025-11-25
- 2025-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $20.10M.
- 2024-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $23.80M.
- 2023-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $9.10M.
- 2022-09-30: Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals $10.30M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals |
|---|---|
| 2025-09-30 | $20.10M 10-K · filed 2025-11-25 |
| 2024-09-30 | $23.80M 10-K · filed 2025-11-25 |
| 2023-09-30 | $9.10M 10-K · filed 2024-12-11 |
| 2022-09-30 | $10.30M 10-K · filed 2023-11-29 |
| 2021-09-30 | $5.30M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |